139 related articles for article (PubMed ID: 36651704)
1. Iodine nutritional status is not a direct factor in the prevalence of the
Lin YY; Hsieh YS
Arch Endocrinol Metab; 2023 Mar; 67(2):172-178. PubMed ID: 36651704
[TBL] [Abstract][Full Text] [Related]
2. Iodine intake as a risk factor for BRAF mutations in papillary thyroid cancer patients from an iodine-replete area.
Kim HJ; Park HK; Byun DW; Suh K; Yoo MH; Min YK; Kim SW; Chung JH
Eur J Nutr; 2018 Mar; 57(2):809-815. PubMed ID: 28258306
[TBL] [Abstract][Full Text] [Related]
3. The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis.
Zhang X; Zhang F; Li Q; Aihaiti R; Feng C; Chen D; Zhao X; Teng W
Front Endocrinol (Lausanne); 2022; 13():1049423. PubMed ID: 36387866
[TBL] [Abstract][Full Text] [Related]
4. Positive
Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
[TBL] [Abstract][Full Text] [Related]
5. Radiomics in predicting mutation status for thyroid cancer: A preliminary study using radiomics features for predicting BRAFV600E mutations in papillary thyroid carcinoma.
Yoon JH; Han K; Lee E; Lee J; Kim EK; Moon HJ; Park VY; Nam KH; Kwak JY
PLoS One; 2020; 15(2):e0228968. PubMed ID: 32053670
[TBL] [Abstract][Full Text] [Related]
6. High iodine intake and central lymph node metastasis risk of papillary thyroid cancer.
Zhao H; Li H; Huang T
J Trace Elem Med Biol; 2019 May; 53():16-21. PubMed ID: 30910201
[TBL] [Abstract][Full Text] [Related]
7. Association between Iodine Intake, Thyroid Function, and Papillary Thyroid Cancer: A Case-Control Study.
Kim K; Cho SW; Park YJ; Lee KE; Lee DW; Park SK
Endocrinol Metab (Seoul); 2021 Aug; 36(4):790-799. PubMed ID: 34376043
[TBL] [Abstract][Full Text] [Related]
8. Elevated BANCR expression levels have different effects on papillary thyroid carcinoma progression depending on the presence of the BRAFV600E mutation.
Stojanović S; Šelemetjev S; Đorić I; Rončević J; Janković Miljuš J; Živaljević V; Išić Denčić T
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1835-1842. PubMed ID: 32651027
[TBL] [Abstract][Full Text] [Related]
9. A different prognostic value of BRAFV600E mutation positivity in various age groups of patients with papillary thyroid cancer.
Takacsova E; Kralik R; Waczulikova I; Zavodna K; Kausitz J
Neoplasma; 2017; 64(1):156-164. PubMed ID: 27881018
[TBL] [Abstract][Full Text] [Related]
10. Active and Passive Smoking, BRAFV600E Mutation Status, and the Risk of Papillary Thyroid Cancer: A Large-Scale Case-Control and Case-Only Study.
Kim KN; Hwang Y; Kim K; Lee KE; Park YJ; Choi JY; Park DJ; Cho B; Kang D; Park SK
Cancer Res Treat; 2019 Oct; 51(4):1392-1399. PubMed ID: 30786705
[TBL] [Abstract][Full Text] [Related]
11. The clinical significance of BRAFV600E mutations in pediatric papillary thyroid carcinomas.
Li Y; Wang Y; Li L; Qiu X
Sci Rep; 2022 Jul; 12(1):12674. PubMed ID: 35879379
[TBL] [Abstract][Full Text] [Related]
12. Non-Iodine-Avid Disease Is Highly Prevalent in Distant Metastatic Differentiated Thyroid Cancer With Papillary Histology.
Soe MH; Chiang JM; Flavell RR; Khanafshar E; Mendoza L; Kang H; Liu C
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3206-e3216. PubMed ID: 35556126
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Iodine Status among Korean Patients with Papillary Thyroid Cancer Using Dietary and Urinary Iodine.
Choi JY; Lee JH; Song Y
Endocrinol Metab (Seoul); 2021 Jun; 36(3):607-618. PubMed ID: 34154044
[TBL] [Abstract][Full Text] [Related]
14. Thyroid Fine Needle Aspiration, the Bethesda System, and the BRAFV600E Mutation in Papillary Thyroid Carcinoma: Association and Prediction for Biopsy.
Galán-García ME; Martínez-Martin MS; Araujo-Ruano EJ; Loro-Ferrer JF; Saavedra-Santana P; Salido-Ruiz E; Cabrera-Galván JJ
Acta Cytol; 2023; 67(4):346-356. PubMed ID: 36592623
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis.
Kim SK; Song KH; Lim SD; Lim YC; Yoo YB; Kim JS; Hwang TS
Thyroid; 2009 Feb; 19(2):137-41. PubMed ID: 19014278
[TBL] [Abstract][Full Text] [Related]
16. X-linked inhibitor of apoptosis protein (XIAP) predicts disease-free survival in
Parvathareddy SK; Siraj AK; Bu R; Iqbal K; Al-Rasheed M; Al-Haqawi W; Annaiyappanaidu P; Siraj N; Ahmed SO; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
Front Endocrinol (Lausanne); 2022; 13():1054882. PubMed ID: 36578953
[TBL] [Abstract][Full Text] [Related]
17. The predictive value of coexisting BRAFV600E and TERT promoter mutations on poor outcomes and high tumour aggressiveness in papillary thyroid carcinoma: A systematic review and meta-analysis.
Chen B; Shi Y; Xu Y; Zhang J
Clin Endocrinol (Oxf); 2021 May; 94(5):731-742. PubMed ID: 32816325
[TBL] [Abstract][Full Text] [Related]
18. Urinary iodine is increased in papillary thyroid carcinoma but is not altered by regional population iodine intake status: a meta-analysis and implications.
Yan AR; Zhang X; Shen H; Zhou X; Li R; Yuan Z
Endocr J; 2019 Jun; 66(6):497-514. PubMed ID: 30890682
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the association of BRAFV600E mutation and Ki-67 overexpression with clinical and pathological characteristics in papillary thyroid cancer.
Espenbetova M; Krykpayeva A; Zamanbekova Z; Zhumanbaeva Z; Azizov B; Mukanova A; Glushkova N
Radiat Environ Biophys; 2021 May; 60(2):233-241. PubMed ID: 33774706
[TBL] [Abstract][Full Text] [Related]
20. Application of Ultrasound Shear Wave Elastography Combined With BRAFV600E Mutation for the Diagnosis of Papillary Thyroid Carcinoma.
Xu L; Haitao R; Li Z
Ultrasound Q; 2023 Dec; 39(4):199-205. PubMed ID: 37543733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
